REMUNITYPRO Trademark

Trademark Overview

On Thursday, June 13, 2024, a trademark application was filed for REMUNITYPRO with the United States Patent and Trademark Office. The USPTO has given the REMUNITYPRO trademark a serial number of 98598857. The federal status of this trademark filing is REGISTERED as of Tuesday, April 14, 2026. This trademark is owned by United Therapeutics Corporation. The REMUNITYPRO trademark is filed in the Medical Instrument Products category with the following description:

Drug delivery systems, namely, pump injectors for the subcutaneous delivery of medication
remunitypro

General Information

Serial Number98598857
Word MarkREMUNITYPRO
Filing DateThursday, June 13, 2024
Status700 - REGISTERED
Status DateTuesday, April 14, 2026
Registration Number8216109
Registration DateTuesday, April 14, 2026
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 4, 2025

Trademark Statements

Goods and ServicesDrug delivery systems, namely, pump injectors for the subcutaneous delivery of medication
Pseudo MarkREMUNITY PRO

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, June 13, 2024
Primary Code010
First Use Anywhere DateMonday, April 7, 2025
First Use In Commerce DateMonday, April 7, 2025

Trademark Owner History

Party NameUnited Therapeutics Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910
US
Party NameUnited Therapeutics Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910
US
Party NameUnited Therapeutics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910
US

Trademark Events

Event DateEvent Description
Thursday, June 13, 2024NEW APPLICATION ENTERED
Wednesday, January 1, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 2, 2025ASSIGNED TO EXAMINER
Monday, January 13, 2025EXAMINERS AMENDMENT -WRITTEN
Monday, January 13, 2025EXAMINERS AMENDMENT E-MAILED
Monday, January 13, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 13, 2025EXAMINER'S AMENDMENT ENTERED
Monday, January 13, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 29, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 4, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 4, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 1, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 23, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, September 23, 2025SOU EXTENSION 1 FILED
Tuesday, September 23, 2025SOU EXTENSION 1 GRANTED
Tuesday, September 23, 2025TEAS STATEMENT OF USE RECEIVED
Wednesday, September 24, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 26, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 23, 2025USE AMENDMENT FILED
Thursday, March 26, 2026STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 26, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 26, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 14, 2026REGISTERED-PRINCIPAL REGISTER
Tuesday, April 14, 2026NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

remunitypro delivery subcutaneous medication injectors namely systems drug pump